Erratum: Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

J Clin Oncol. 2023 Sep 13:JCO2301849. doi: 10.1200/JCO.23.01849. Online ahead of print.NO ABSTRACTPMID:37703508 | DOI:10.1200/JCO.23.01849
Source: Clinical Lung Cancer - Category: Cancer & Oncology Source Type: research